Last updated: Oct 30, 2026, 12:00 AM

Contineum Therapeutics, Inc. Class A Common Stock Exchange (NASDAQ, USD)

CTNM

-
+0.18 (+1.97%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-15.41%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
307.50M
Price/Sales
-
Ent value
303.50M
Price/Book
1.28
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Ready to capitalize on Contineum Therapeutics, Inc. Class A Common Stock's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
CTNMS&P500
Current price drop from All-time high-56.83%-3.00%
Highest price drop-84.37%-56.47%
Date of highest drop28 May 20259 Mar 2009
Avg drop from high-40.50%-10.65%
Avg time to new high36 days12 days
Max time to new high576 days1805 days